Can a smartphone app keep young leukemia patients on track?

NCT ID NCT03932903

Recruiting now Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tests a mobile app called ADAPTS designed to help teenagers and young adults with leukemia remember to take their oral chemotherapy. The app sends personalized messages based on the user's mood, pain, or location. The goal is to see if the app is easy to use and acceptable to patients, not yet to measure health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ADAPTS mobile app intervention
What this could lead to: If successful, this could point toward a practical tool to help young patients take their chemotherapy as prescribed, potentially improving treatment outcomes.
What could go wrong: This is a very early feasibility study with only 60 participants, so it won't prove the app improves health. Technical glitches or low engagement may limit its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia lymphoblastic lymphoma neoplasm Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LYMPHOBLASTIC LEUKEMIA LYMPHOBLASTIC LYMPHOMA

Contacts and locations

Locations

Robert H. Lurie Comprehensive Cancer Center, Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.